AAV5 exhibits unique transcriptional features compared to AAV2, including a smaller intron, independence from Rep protein for promoter activity, and unique polyadenylation sites.
No takes yet. Share an insight, caveat, or question.
AAV5 transcriptional features may guide vector engineering; leaves open translation to clinical gene therapy applications.
Qiu et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: